The remarkable technologic and methodologic advances spurred on by the Huma
n Genome Project are being applied throughout the life sciences. In the fie
ld of toxicology, high-resolution assays now make it possible to discover v
irtually all the differences in gene expression brought on by exposure to a
particular xenobiotic. There are 2 principal approaches used to build a ca
talog of changes in gene expression: hybridization microarrays and gel-base
d methods, such as differential display and AFLP(TM)-based mRNA fingerprint
ing. The power of such approaches is exemplified by the identification of m
ore than 300 genes that differ in expression level by at least 2-fold in re
sponse to the nongenotoxic rodent liver carcinogen phenobarbital.